OPKO Health PE Ratio 2010-2024 | OPK
Current and historical p/e ratio for OPKO Health (OPK) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. OPKO Health PE ratio as of August 30, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
OPKO Health PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-08-30 | 1.68 | 0.00 | |
2024-06-30 | 1.25 | $-0.33 | 0.00 |
2024-03-31 | 1.20 | $-0.35 | 0.00 |
2023-12-31 | 1.51 | $-0.25 | 0.00 |
2023-09-30 | 1.60 | $-0.27 | 0.00 |
2023-06-30 | 2.17 | $-0.27 | 0.00 |
2023-03-31 | 1.46 | $-0.38 | 0.00 |
2022-12-31 | 1.25 | $-0.47 | 0.00 |
2022-09-30 | 1.89 | $-0.32 | 0.00 |
2022-06-30 | 2.53 | $-0.24 | 0.00 |
2021-12-31 | 4.81 | $-0.05 | 0.00 |
2021-09-30 | 3.65 | $0.11 | 33.18 |
2021-06-30 | 4.05 | $-0.01 | 0.00 |
2021-03-31 | 4.29 | $0.06 | 71.50 |
2020-12-31 | 3.95 | $0.06 | 65.83 |
2022-03-31 | 3.44 | $-0.08 | 0.00 |
2020-09-30 | 3.69 | $-0.18 | 0.00 |
2020-06-30 | 3.41 | $-0.33 | 0.00 |
2020-03-31 | 1.34 | $-0.48 | 0.00 |
2019-12-31 | 1.47 | $-0.53 | 0.00 |
2019-09-30 | 2.09 | $-0.48 | 0.00 |
2019-06-30 | 2.44 | $-0.42 | 0.00 |
2019-03-31 | 2.61 | $-0.33 | 0.00 |
2018-12-31 | 3.01 | $-0.27 | 0.00 |
2018-09-30 | 3.46 | $-0.52 | 0.00 |
2018-06-30 | 4.70 | $-0.55 | 0.00 |
2018-03-31 | 3.17 | $-0.58 | 0.00 |
2017-12-31 | 4.90 | $-0.56 | 0.00 |
2017-09-30 | 6.86 | $-0.22 | 0.00 |
2017-06-30 | 6.58 | $-0.17 | 0.00 |
2017-03-31 | 8.00 | $-0.11 | 0.00 |
2016-12-31 | 9.30 | $-0.07 | 0.00 |
2016-09-30 | 10.59 | $-0.03 | 0.00 |
2016-06-30 | 9.34 | $0.25 | 37.36 |
2016-03-31 | 10.39 | $0.14 | 74.21 |
2015-12-31 | 10.05 | $0.04 | 251.25 |
2015-09-30 | 8.41 | $-0.07 | 0.00 |
2015-06-30 | 16.08 | $-0.38 | 0.00 |
2014-12-31 | 9.99 | $-0.40 | 0.00 |
2014-09-30 | 8.51 | $-0.32 | 0.00 |
2014-06-30 | 8.84 | $-0.47 | 0.00 |
2014-03-31 | 9.32 | $-0.58 | 0.00 |
2013-12-31 | 8.44 | $-0.48 | 0.00 |
2015-03-31 | 14.17 | $-0.55 | 0.00 |
2013-09-30 | 8.81 | $-0.29 | 0.00 |
2013-06-30 | 7.10 | $-0.15 | 0.00 |
2013-03-31 | 7.63 | $-0.18 | 0.00 |
2012-12-31 | 4.81 | $-0.10 | 0.00 |
2012-09-30 | 4.18 | $-0.04 | 0.00 |
2012-06-30 | 4.60 | $-0.04 | 0.00 |
2012-03-31 | 4.73 | $-0.02 | 0.00 |
2011-12-31 | 4.90 | $-0.01 | 0.00 |
2011-09-30 | 4.33 | $-0.08 | 0.00 |
2011-06-30 | 3.69 | $-0.08 | 0.00 |
2011-03-31 | 3.73 | $-0.09 | 0.00 |
2010-12-31 | 3.67 | $-0.09 | 0.00 |
2010-09-30 | 2.24 | $-0.12 | 0.00 |
2010-06-30 | 2.26 | $-0.09 | 0.00 |
2010-03-31 | 1.98 | $-0.09 | 0.00 |
2009-12-31 | 1.83 | $-0.12 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $1.172B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $234.954B | 28.16 |
Intuitive Surgical (ISRG) | United States | $175.058B | 99.12 |
Alcon (ALC) | Switzerland | $48.180B | 33.92 |
IQVIA Holdings (IQV) | United States | $45.858B | 25.99 |
Edwards Lifesciences (EW) | United States | $42.144B | 27.01 |
IDEXX Laboratories (IDXX) | United States | $39.616B | 47.66 |
DexCom (DXCM) | United States | $27.786B | 39.62 |
STERIS (STE) | Ireland | $23.777B | 27.74 |
SONOVA HOLDING (SONVY) | Switzerland | $20.808B | 0.00 |
Waters (WAT) | United States | $20.560B | 30.65 |
Hologic (HOLX) | United States | $18.870B | 20.52 |
Sysmex ADR (SSMXY) | Japan | $12.134B | 38.05 |
Teleflex (TFX) | United States | $11.552B | 17.96 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.379B | 12.76 |
Globus Medical (GMED) | United States | $9.844B | 27.54 |
Penumbra (PEN) | United States | $7.859B | 81.58 |
Glaukos (GKOS) | United States | $7.357B | 0.00 |
Masimo (MASI) | United States | $6.252B | 33.48 |
TransMedics (TMDX) | United States | $5.606B | 240.09 |
Integer Holdings (ITGR) | United States | $4.361B | 25.50 |
PROCEPT BioRobotics (PRCT) | United States | $4.103B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $2.848B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.736B | 16.05 |
Elekta AB (EKTAY) | Sweden | $2.601B | 21.19 |
Inari Medical (NARI) | United States | $2.519B | 0.00 |
Veracyte (VCYT) | United States | $2.423B | 150.24 |
Nihon Kohden (NHNKY) | Japan | $2.287B | 14.23 |
RxSight (RXST) | United States | $2.086B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.578B | 7.19 |
Pulse Biosciences (PLSE) | United States | $1.142B | 0.00 |
Artivion (AORT) | United States | $1.137B | 104.38 |
AVANOS MEDICAL, INC (AVNS) | United States | $1.113B | 19.85 |
Silk Road Medical (SILK) | United States | $1.102B | 0.00 |
Alphatec Holdings (ATEC) | United States | $0.969B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.774B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.723B | 18.26 |
Paragon 28 (FNA) | United States | $0.695B | 0.00 |
SiBone (SIBN) | United States | $0.693B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
IRadimed (IRMD) | United States | $0.595B | 32.16 |
AxoGen (AXGN) | United States | $0.576B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.373B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
Sight Sciences (SGHT) | United States | $0.341B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.325B | 9.92 |
Delcath Systems (DCTH) | United States | $0.306B | 0.00 |
AngioDynamics (ANGO) | United States | $0.300B | 0.00 |
Inogen (INGN) | United States | $0.291B | 0.00 |
NeuroPace (NPCE) | United States | $0.231B | 0.00 |
Nevro (NVRO) | United States | $0.231B | 0.00 |
Accuray (ARAY) | United States | $0.216B | 0.00 |
CVRx (CVRX) | United States | $0.215B | 0.00 |
Semler Scientific (SMLR) | United States | $0.187B | 13.09 |
Atossa Genetics (ATOS) | United States | $0.172B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
908 Devices (MASS) | United States | $0.137B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.134B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.116B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.107B | 15.90 |
Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
Hyperfine (HYPR) | United States | $0.073B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
InspireMD (NSPR) | Israel | $0.069B | 0.00 |
Envoy Medical (COCH) | United States | $0.059B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.058B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.056B | 0.00 |
LENSAR (LNSR) | United States | $0.054B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.037B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
Precision Optics (POCI) | United States | $0.032B | 0.00 |
ReWalk Robotics (LFWD) | United States | $0.030B | 0.00 |
Neuronetics (STIM) | United States | $0.027B | 0.00 |
Spectral AI (MDAI) | United States | $0.025B | 0.00 |
DarioHealth (DRIO) | United States | $0.024B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
NexGel (NXGL) | United States | $0.018B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.017B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
PAVmed (PAVM) | United States | $0.009B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
Avinger (AVGR) | United States | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |